Patients with pancreatic cancer and its precancerous lesions, and individuals at high risk of developing pancreatic neoplasm, and patients with benign gastrointestinal disorders such as cholelithiasis and gastroduodenal ulcer
Conditions
Interventions
None listed
Sponsors
Asahikawa Medical University
Sapporo Higashi Tokushukai Hospital Asahikawa-Kosei General Hospital Japanese Red Cross Asahikawa Hospital Shibetsu City Hospital Teine Keijinkai Hospital Engaru-Kosei General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ?Patients with malignant pancreatic tumor and benign/pre-cancerous lesions. ?Individuals at high risk of developing pancreatic neoplasm. ?Patients with benign digestive disorder who receive upper endoscopic examination. ?Patients with written informed consent.
Exclusion criteria
Exclusion criteria: ?Patients with severe heart disease ?Patients with severe renal disease ?Patients with serious mental illness ?Patients complicated with severe infection ?Patients with severe diabetes ?Patients with severe dehydration and malnutrition ?Patients who have other serious complications and are considered difficult to participate ?Patient who judged inappropriate by an attendant physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic value of quantitative detection and monitoring of tumor-associated alterations in circulating cell-free nucleic acid and tissue-derived nucleic acid for the diagnosis of pancreatic neoplasm. | — |
Secondary
| Measure | Time frame |
|---|---|
| Surveillance of individuals at high risk of developing pancreatic neoplasm by quantitative detection and monitoring of tumor-associated alterations in cell-free nucleic acid and tissue-derived nucleic acid. | — |
Countries
Japan
Contacts
Public ContactYusuke Mizukami
Asahikawa Medical University Cancer Genomics and Precision Medicine Department of Medicine
Outcome results
None listed